Results · Apr-Jun 2026 · filed 7 Aug 2026
Evexia Lifecare Q1 FY27 results
Sales grew 40% to ₹30.9 crore from ₹22.1 crore in Apr-Jun 2025.
Operating profit fell 50% to ₹0.54 crore, an operating margin of 1.7% (down 3.1 points from a year ago).
Net profit fell 34% to ₹0.42 crore from ₹0.63 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −16%, net profit −46%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 30.9 | 22.1 | +40% |
| Operating profit (EBITDA) | 0.5 | 1.1 | −50% |
| Operating margin | 1.7% | 4.9% | −3.1 pts |
| Net profit | 0.4 | 0.6 | −34% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026
- 7 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026
- 5 Aug 2026Corrigendum To Intimation Of Board Meeting To Be Held On Friday, August 07, 2026
- 4 Aug 2026Board Meeting Intimation for To Consider And Approve Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended On June 30, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.